trending Market Intelligence /marketintelligence/en/news-insights/trending/U-TB3vAH4Cb4p7-vtij1uw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

US FDA clears PCI Biotech bile duct cancer drug

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


US FDA clears PCI Biotech bile duct cancer drug

The U.S. FDA cleared PCI Biotech Holding ASA's investigational new drug application for fimaporfin for the treatment of inoperable bile duct cancer.

The clearance allows the company to include patients in the U.S. in its phase 2 clinical program for the drug, following early signs of efficacy in phase 1.